These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 14645158)

  • 1. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.
    Tiemessen MM; Kunzmann S; Schmidt-Weber CB; Garssen J; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
    Int Immunol; 2003 Dec; 15(12):1495-504. PubMed ID: 14645158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression.
    Kunzmann S; Wohlfahrt JG; Itoh S; Asao H; Komada M; Akdis CA; Blaser K; Schmidt-Weber CB
    FASEB J; 2003 Feb; 17(2):194-202. PubMed ID: 12554698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta 1 induces antigen-specific unresponsiveness in naive T cells.
    Gilbert KM; Thoman M; Bauche K; Pham T; Weigle WO
    Immunol Invest; 1997 Jun; 26(4):459-72. PubMed ID: 9246566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
    Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
    J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
    Park HB; Paik DJ; Jang E; Hong S; Youn J
    Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TGF-beta response during T cell activation is modulated by IL-10.
    Cottrez F; Groux H
    J Immunol; 2001 Jul; 167(2):773-8. PubMed ID: 11441082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta induces apoptosis in antigen-specific CD4+ T cells prepared for adoptive immunotherapy.
    Chang CJ; Liao CH; Wang FH; Lin CM
    Immunol Lett; 2003 Mar; 86(1):37-43. PubMed ID: 12600743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation.
    McKarns SC; Schwartz RH; Kaminski NE
    J Immunol; 2004 Apr; 172(7):4275-84. PubMed ID: 15034041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
    Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
    J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
    Chen W; Jin W; Wahl SM
    J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans.
    Montagnoli C; Bacci A; Bozza S; Gaziano R; Mosci P; Sharpe AH; Romani L
    J Immunol; 2002 Dec; 169(11):6298-308. PubMed ID: 12444136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice.
    Nakamura K; Kitani A; Fuss I; Pedersen A; Harada N; Nawata H; Strober W
    J Immunol; 2004 Jan; 172(2):834-42. PubMed ID: 14707053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3.
    McKarns SC; Schwartz RH
    J Immunol; 2005 Feb; 174(4):2071-83. PubMed ID: 15699137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.